451 related articles for article (PubMed ID: 25584011)
1. Blocking follistatin-like 1 attenuates bleomycin-induced pulmonary fibrosis in mice.
Dong Y; Geng Y; Li L; Li X; Yan X; Fang Y; Li X; Dong S; Liu X; Li X; Yang X; Zheng X; Xie T; Liang J; Dai H; Liu X; Yin Z; Noble PW; Jiang D; Ning W
J Exp Med; 2015 Feb; 212(2):235-52. PubMed ID: 25584011
[TBL] [Abstract][Full Text] [Related]
2. Follistatin-Like 1 Promotes Bleomycin-Induced Pulmonary Fibrosis through the Transforming Growth Factor Beta 1/Mitogen-Activated Protein Kinase Signaling Pathway.
Jin YK; Li XH; Wang W; Liu J; Zhang W; Fang YS; Zhang ZF; Dai HP; Ning W; Wang C
Chin Med J (Engl); 2018 Aug; 131(16):1917-1925. PubMed ID: 30082522
[TBL] [Abstract][Full Text] [Related]
3. Fibroblast growth factor 2 is required for epithelial recovery, but not for pulmonary fibrosis, in response to bleomycin.
Guzy RD; Stoilov I; Elton TJ; Mecham RP; Ornitz DM
Am J Respir Cell Mol Biol; 2015 Jan; 52(1):116-28. PubMed ID: 24988442
[TBL] [Abstract][Full Text] [Related]
4. Targeting Follistatin like 1 ameliorates liver fibrosis induced by carbon tetrachloride through TGF-β1-miR29a in mice.
Xu XY; Du Y; Liu X; Ren Y; Dong Y; Xu HY; Shi JS; Jiang D; Xu X; Li L; Xu ZH; Geng Y
Cell Commun Signal; 2020 Sep; 18(1):151. PubMed ID: 32933544
[TBL] [Abstract][Full Text] [Related]
5. Altered Expression of Bone Morphogenetic Protein Accessory Proteins in Murine and Human Pulmonary Fibrosis.
Murphy N; Gaynor KU; Rowan SC; Walsh SM; Fabre A; Boylan J; Keane MP; McLoughlin P
Am J Pathol; 2016 Mar; 186(3):600-15. PubMed ID: 26765958
[TBL] [Abstract][Full Text] [Related]
6. ERK5 inhibition ameliorates pulmonary fibrosis via regulating Smad3 acetylation.
Kim S; Lim JH; Woo CH
Am J Pathol; 2013 Dec; 183(6):1758-1768. PubMed ID: 24095924
[TBL] [Abstract][Full Text] [Related]
7. Targeting FSTL1 for Multiple Fibrotic and Systemic Autoimmune Diseases.
Li X; Fang Y; Jiang D; Dong Y; Liu Y; Zhang S; Guo J; Qi C; Zhao C; Jiang F; Jin Y; Geng J; Yang C; Zhang H; Wei B; Liang J; Wang C; Dai H; Zhou H; Jiang D; Ning W
Mol Ther; 2021 Jan; 29(1):347-364. PubMed ID: 33007201
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of bleomycin-induced pulmonary fibrosis by bone marrow-derived mesenchymal stem cells might be mediated by decreasing MMP9, TIMP-1, INF-γ and TGF-β.
Yu SH; Liu LJ; Lv B; Che CL; Fan DP; Wang LF; Zhang YM
Cell Biochem Funct; 2015 Aug; 33(6):356-66. PubMed ID: 26178702
[TBL] [Abstract][Full Text] [Related]
9. Follistatin-like 1 (Fstl1) is a bone morphogenetic protein (BMP) 4 signaling antagonist in controlling mouse lung development.
Geng Y; Dong Y; Yu M; Zhang L; Yan X; Sun J; Qiao L; Geng H; Nakajima M; Furuichi T; Ikegawa S; Gao X; Chen YG; Jiang D; Ning W
Proc Natl Acad Sci U S A; 2011 Apr; 108(17):7058-63. PubMed ID: 21482757
[TBL] [Abstract][Full Text] [Related]
10. Sphingolipids in pulmonary fibrosis.
Huang LS; Natarajan V
Adv Biol Regul; 2015 Jan; 57():55-63. PubMed ID: 25446881
[TBL] [Abstract][Full Text] [Related]
11. Follistatin like-1 aggravates silica-induced mouse lung injury.
Fang Y; Zhang S; Li X; Jiang F; Ye Q; Ning W
Sci Rep; 2017 Mar; 7(1):399. PubMed ID: 28341862
[TBL] [Abstract][Full Text] [Related]
12. Haplodeletion of Follistatin-Like 1 Attenuates Radiation-Induced Pulmonary Fibrosis in Mice.
Chen Z; Fang Y; Zhang S; Li L; Wang L; Zhang A; Yuan Z; Wang P; Zhou H; Cui W; MacVittie TJ; Ning W
Int J Radiat Oncol Biol Phys; 2019 Jan; 103(1):208-216. PubMed ID: 30171878
[TBL] [Abstract][Full Text] [Related]
13. Enhanced endogenous bone morphogenetic protein signaling protects against bleomycin induced pulmonary fibrosis.
De Langhe E; Cailotto F; De Vooght V; Aznar-Lopez C; Vanoirbeek JA; Luyten FP; Lories RJ
Respir Res; 2015 Mar; 16(1):38. PubMed ID: 25849157
[TBL] [Abstract][Full Text] [Related]
14. TGF-β1 induces Fstl1 via the Smad3-c-Jun pathway in lung fibroblasts.
Zheng X; Qi C; Zhang S; Fang Y; Ning W
Am J Physiol Lung Cell Mol Physiol; 2017 Aug; 313(2):L240-L251. PubMed ID: 28495857
[TBL] [Abstract][Full Text] [Related]
15. Follistatin-like 1 attenuates differentiation and survival of erythroid cells through Smad2/3 signaling.
Wu J; Dong Y; Teng X; Cheng M; Shen Z; Chen W
Biochem Biophys Res Commun; 2015 Oct; 466(4):711-6. PubMed ID: 26365350
[TBL] [Abstract][Full Text] [Related]
16. Role of A
Liu B; Bing Q; Li S; Han B; Lu J; Baiyun R; Zhang X; Lv Y; Wu H; Zhang Z
J Nanobiotechnology; 2019 Mar; 17(1):45. PubMed ID: 30922349
[TBL] [Abstract][Full Text] [Related]
17. Oxymatrine attenuates bleomycin-induced pulmonary fibrosis in mice via the inhibition of inducible nitric oxide synthase expression and the TGF-β/Smad signaling pathway.
Liu L; Lu W; Ma Z; Li Z
Int J Mol Med; 2012 May; 29(5):815-22. PubMed ID: 22367596
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of Fstl1 attenuates hepatic stellate cell activation through the TGF‑β1/Smad3 signaling pathway.
Shang H; Liu X; Guo H
Mol Med Rep; 2017 Nov; 16(5):7119-7123. PubMed ID: 28901425
[TBL] [Abstract][Full Text] [Related]
19. Surfactant protein D attenuates sub-epithelial fibrosis in allergic airways disease through TGF-β.
Ogawa H; Ledford JG; Mukherjee S; Aono Y; Nishioka Y; Lee JJ; Izumi K; Hollingsworth JW
Respir Res; 2014 Nov; 15(1):143. PubMed ID: 25472740
[TBL] [Abstract][Full Text] [Related]
20. CXCL6 antibody neutralization prevents lung inflammation and fibrosis in mice in the bleomycin model.
Besnard AG; Struyf S; Guabiraba R; Fauconnier L; Rouxel N; Proost P; Uyttenhove C; Van Snick J; Couillin I; Ryffel B
J Leukoc Biol; 2013 Dec; 94(6):1317-23. PubMed ID: 23975892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
